TASK DEFINITION: In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
PROBLEM: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Tiffany Joslyn Juvenile
Accountability Block Grant Program Reauthorization Act of 2016''.

SEC. 2. REAUTHORIZATION OF JUVENILE ACCOUNTABILITY BLOCK GRANT PROGRAM.

Part R of title I of the Omnibus Crime Control and Safe Streets Act
of 1968 (42 U.S.C. 3796ee et seq.) is amended--
(1) in section 1801(b)--
(A) in paragraph (1), by striking ''graduated
sanctions'' and inserting ''graduated sanctions and
incentives''; and
(B) in paragraph (3), by striking ''hiring juvenile
court judges, probation officers, and court-appointed
defenders and special advocates, and'';
(C) by striking paragraphs (4) and (7), and
redesignating paragraphs (5) through (17) as paragraphs
(4) through (15), respectively; and
(D) in paragraph (11), as so redesignated, by
striking ''research-based bullying, cyberbullying, and
gang prevention programs'' and inserting
''interventions such as researched-based anti-bullying,
anti-cyberbullying, and gang prevention programs, as
well as mental health services and trauma-informed
practices'';
(2) in section 1802--
(A) in subsection (d)(3), by inserting after
''individualized sanctions'' the following: '',
incentives,'';
(B) in subsection (e)(1)(B), by striking
''graduated sanctions'' and inserting ''graduated
sanctions and incentives''; and
(C) in subsection (f)--
(i) in paragraph (2)--
(I) by inserting after ''A sanction
may include'' the following: ''a range
of court-approved interventions, such
as''; and
(II) by inserting after ''a fine,''
the following: ''a restorative justice
program,''; and
(ii) by inserting after paragraph (2) the
following:
''(3) Incentives.--The term 'incentives' means
individualized, goal-oriented, and graduated responses to a
juvenile offender's compliance with court orders and case
disposition terms designed to reinforce or modify the skills
and behaviors of the juvenile offender. An incentive may
include a certificate of achievement, a letter of
recommendation, a family or program activity, a meeting or
special outing with a community leader, a reduction in
community service hours, a reduced curfew or home-restriction,
a decrease in required court appearances, or a decrease in the
term of court-ordered supervision.'';
(3) in section 1810(a), by striking ''$350,000,000 for each
of fiscal years 2006 through 2009'' and inserting ''$25,000,000
for each of fiscal years 2018 through 2022''; and
(4) by adding at the end the following:

''SEC. 1811. GRANT ACCOUNTABILITY.

''(a) Definition of Applicable Committees.--In this section, the
term 'applicable committees' means--
''(1) the Committee on the Judiciary of the Senate; and
''(2) the Committee on the Judiciary of the House of
Representatives.
''(b) Accountability.--All grants awarded by the Attorney General
under this part shall be subject to the following accountability
provisions:
''(1) Audit requirement.--
''(A) Definition.--In this paragraph, the term
'unresolved audit finding' means a finding in the final
audit report of the Inspector General of the Department
of Justice that the audited grantee has utilized grant
funds for an unauthorized expenditure or otherwise
unallowable cost that is not closed or resolved within
12 months after the date on which the final audit
report is issued.
''(B) Audit.--Beginning in the first fiscal year
beginning after the date of enactment of this section,
and in each fiscal year thereafter, the Inspector
General of the Department of Justice shall conduct
audits of recipients of grants awarded by the Attorney
General under this part to prevent waste, fraud, and
abuse of funds by grantees. The Inspector General shall
determine the appropriate number of grantees to be
audited each year.
''(C) Mandatory exclusion.--A recipient of grant
funds under this part that is found to have an
unresolved audit finding shall not be eligible to
receive grant funds under this part during the first 2
fiscal years beginning after the end of the 12-month
period described in subparagraph (A).
''(D) Priority.--In awarding grants under this
part, the Attorney General shall give priority to
eligible applicants that did not have an unresolved
audit finding during the 3 fiscal years before
submitting an application for a grant under this part.
''(E) Reimbursement.--If an entity is awarded grant
funds under this part during the 2-fiscal-year period
during which the entity is barred from receiving grants
under subparagraph (C), the Attorney General shall--
''(i) deposit an amount equal to the amount
of the grant funds that were improperly awarded
to the grantee into the General Fund of the
Treasury; and
''(ii) seek to recoup the costs of the
repayment to the fund from the grant recipient
that was erroneously awarded grant funds.
''(2) Annual certification.--Beginning in the first fiscal
year beginning after the date of enactment of this section, the
Attorney General shall submit to the applicable committees an
annual certification--
''(A) indicating whether--
''(i) all audits issued by the Inspector
General of the Department of Justice under
paragraph (1) have been completed and reviewed
by the appropriate Assistant Attorney General
or Director;
''(ii) all mandatory exclusions required
under paragraph (1)(C) have been issued; and
''(iii) all reimbursements required under
paragraph (1)(E) have been made; and
''(B) that includes a list of any grant recipients
excluded under paragraph (1) from the previous year.
''(c) Preventing Duplicative Grants.--
''(1) In general.--Before the Attorney General awards a
grant to an applicant under this part, the Attorney General
shall compare potential grant awards with other grants awarded
under this part by the Attorney General to determine if
duplicate grant awards are awarded for the same purpose.
''(2) Report.--If the Attorney General awards duplicate
grants under this part to the same applicant for the same
purpose, the Attorney General shall submit to the applicable
committees a report that includes--
''(A) a list of all duplicate grants awarded under
this part, including the total dollar amount of any
duplicate grants awarded; and
''(B) the reason the Attorney General awarded the
duplicate grants.''.

SEC. 3. SENSE OF CONGRESS.

It is the sense of the Congress that the use of best practices is
encouraged for all activities for which grants under part R of title I
of the Omnibus Crime Control and Safe Streets Act of 1968 may be used.

SEC. 4. USE OF AMOUNTS MADE AVAILABLE FOR DEPARTMENT OF JUSTICE,
GENERAL ADMINISTRATION TO CARRY OUT JUVENILE
ACCOUNTABILITY BLOCK GRANT PROGRAM.

In each of fiscal years 2018 through 2022, the Attorney General
shall use up to $25,000,000 of the amounts made available for
Department of Justice, General Administration, to carry out part R of
title I of the Omnibus Crime Control and Safe Streets Act of 1968 (42
U.S.C. 3796ee et seq.).
Amend the title so as to read: ''A bill to amend the
Omnibus Crime Control and Safe Streets Act of 1968 to
reauthorize the Juvenile Accountability Block Grant program,
and for other purposes.''.

SOLUTION: Tiffany Joslyn Juvenile Accountability Block Grant Program Reauthorization Act of 2016 (Sec. 2) This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to revise and reauthorize through FY2022 the Juvenile Accountability Block Grant (JABG) Program. It subjects JABG grants to accountability measures. The Department of Justice's (DOJ's) Office of Inspector General must conduct annual audits of selected grant recipients. DOJ must submit an annual certification to Congress and identify and report on duplicative grant awards. (Sec. 3) The bill expresses the sense of Congress that the use of best practices is encouraged for activities carried out with JABG funds. (Sec. 4) DOJ must use amounts made available for general administration to carry out the JABG Program.

PROBLEM: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Prescription Drug Fairness for
Seniors Act of 2001''.

SEC. 2. FINDINGS AND PURPOSES.

(a) Findings.--The Congress finds the following:
(1) Manufacturers of prescription drugs engage in price
discrimination practices that compel many older Americans to
pay substantially more for prescription drugs than consumers in
foreign nations and the drug manufacturers' most favored U.S.
customers, such as health insurers, health maintenance
organizations, and the Federal Government.
(2) Older Americans who buy their own prescription drugs
often pay twice as much for prescription drugs as consumers in
foreign nations and the drug manufacturers' most favored U.S.
customers. In some cases, older Americans pay 10 times more for
prescription drugs than such customers.
(3) The discriminatory pricing by major drug manufacturers
sustains their high profits (for example, $27,300,000,000 in
1999), but causes financial hardship and impairs the health and
well-being of millions of older Americans. Many older Americans
are forced to choose between buying their food and buying their
medicines.
(4) Foreign nations and U.S. federally funded health care
programs use purchasing power to obtain prescription drugs at
low prices. Medicare beneficiaries are denied this benefit and
cannot obtain their prescription drugs at the lower prices
available to such nations and programs.
(5) Implementation of the policy set forth in this Act will
reduce prices for brand name prescription drugs for many
Medicare beneficiaries by an average of 40 percent.
(6) In addition to substantially lowering the costs of
prescription drugs for older Americans, implementation of the
policy set forth in this Act will significantly improve the
health and well-being of older Americans and lower the costs to
the Federal taxpayer of the Medicare program.
(7) Older Americans who are terminally ill and receiving
hospice care services represent some of the most vulnerable
individuals in our nation. Making prescription drugs available
to Medicare beneficiaries under the care of Medicare-certified
hospices will assist in extending the benefits of lower
prescription drug prices to those most vulnerable and in need.
(b) Purpose.--The purpose of this Act is to protect Medicare
beneficiaries from discriminatory pricing by drug manufacturers and to
make prescription drugs available to Medicare beneficiaries at
substantially reduced prices.

SEC. 3. PARTICIPATING MANUFACTURERS.

(a) In General.--Each participating manufacturer of a covered
outpatient drug shall make available for purchase by each pharmacy such
covered outpatient drug in the amount described in subsection (b) at
the price described in subsection (c).
(b) Description of Amount of Drugs.--The amount of a covered
outpatient drug that a participating manufacturer shall make available
for purchase by a pharmacy is an amount equal to the aggregate amount
of the covered outpatient drug sold or distributed by the pharmacy to
Medicare beneficiaries.
(c) Description of Price.--The price at which a participating
manufacturer shall make a covered outpatient drug available for
purchase by a pharmacy is a price no greater than the manufacturer's
average foreign price.
(d) Enforcement.--The United States shall debar a manufacturer of
drugs or biologicals that does not comply with the provisions of this
Act.

SEC. 4. SPECIAL PROVISION WITH RESPECT TO HOSPICE PROGRAMS.

For purposes of determining the amount of a covered outpatient drug
that a participating manufacturer shall make available for purchase by
a pharmacy under section 3, there shall be included in the calculation
of such amount the amount of the covered outpatient drug sold or
distributed by a pharmacy to a hospice program. In calculating such
amount, only amounts of the covered outpatient drug furnished to a
Medicare beneficiary enrolled in the hospice program shall be included.

SEC. 5. ADMINISTRATION.

The Secretary shall issue such regulations as may be necessary to
implement this Act.

SEC. 6. REPORTS TO CONGRESS REGARDING EFFECTIVENESS OF ACT.

(a) In General.--Not later than 2 years after the date of the
enactment of this Act, and annually thereafter, the Secretary shall
report to the Congress regarding the effectiveness of this Act in--
(1) protecting Medicare beneficiaries from discriminatory
pricing by drug manufacturers, and
(2) making prescription drugs available to Medicare
beneficiaries at substantially reduced prices.
(b) Consultation.--In preparing such reports, the Secretary shall
consult with public health experts, affected industries, organizations
representing consumers and older Americans, and other interested
persons.
(c) Recommendations.--The Secretary shall include in such reports
any recommendations the Secretary considers appropriate for changes in
this Act to further reduce the cost of covered outpatient drugs to
Medicare beneficiaries.

SEC. 7. DEFINITIONS.

In this Act:
(1) Average foreign price.--
(A) In general.--The term ''average foreign price''
means, with respect to a covered outpatient drug, the
average price that the manufacturer of the drug
realizes on the sale of drugs with the same active
ingredient or ingredients that are consumed in covered
foreign nations, taking into account--
(i) any rebate, contract term or condition,
or other arrangement (whether with the
purchaser or other persons) that has the effect
of reducing the amount realized by the
manufacturer on the sale of the drugs; and
(ii) adjustments for any differences in
dosage, formulation, or other relevant
characteristics of the drugs.
(B) Exempt transactions.--The Secretary may, by
regulation, exempt from the calculation of the average
foreign price of a drug those prices realized by a
manufacturer in transactions that are entered into for
charitable purposes, for research purposes, or under
other unusual circumstances, if the Secretary
determines that the exemption is in the public interest
and is consistent with the purposes of this Act.
(2) Covered foreign nation.--The term ''covered foreign
nation' means Canada, France, Germany, Italy, Japan, and the
United Kingdom.
(3) Covered outpatient drug.--The term ''covered outpatient
drug'' has the meaning given that term in section 1927(k)(2) of
the Social Security Act (42 U.S.C. 1396r-8(k)(2)).
(4) Debar.--The term ''debar'' means to exclude, pursuant
to established administrative procedures, from Government
contracting and subcontracting for a specified period of time
commensurate with the seriousness of the failure or offense or
the inadequacy of performance.
(5) Hospice program.--The term ''hospice program'' has the
meaning given that term under section 1861(dd)(2) of the Social
Security Act (42 U.S.C. 1395x(dd)(2)).
(6) Medicare beneficiary.--The term ''Medicare
beneficiary'' means an individual entitled to benefits under
part A of title XVIII of the Social Security Act or enrolled
under part B of such title, or both.
(7) Participating manufacturer.--The term ''participating
manufacturer'' means any manufacturer of drugs or biologicals
that, on or after the date of the enactment of this Act, enters
into a contract or agreement with the United States for the
sale or distribution of covered outpatient drugs to the United
States.
(8) Secretary.--The term ''Secretary'' means the Secretary
of Health and Human Services.

SEC. 8. EFFECTIVE DATE.

The Secretary shall implement this Act as expeditiously as
practicable and in a manner consistent with the obligations of the
United States.

SOLUTION: Prescription Drug Fairness for Seniors Act of 2001 - Requires each participating manufacturer of a covered outpatient drug to make it available for purchase by each pharmacy: (1) in an amount equal to the aggregate amount sold or distributed by the pharmacy to Medicare beneficiaries; and (2) at a price no greater than the manufacturer's average foreign price. Sets forth special provisions with respect to hospice programs.

PROBLEM: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Combating Fraud Against Seniors
Act''.

SEC. 2. CENTRALIZED COMPLAINT AND CONSUMER EDUCATION SERVICE FOR
VICTIMS OF TELEMARKETING FRAUD.

(a) Centralized Service.--
(1) Requirement.--The Federal Trade Commission shall, after
consultation with the Attorney General, establish procedures
to--
(A) log and acknowledge the receipt of complaints
by individuals who certify that they have a reasonable
belief that they have been the victim of fraud in
connection with the conduct of telemarketing (as that
term is defined in section 2325 of title 18, United
States Code, as amended by subsection (d) of this
section);
(B) provide to individuals described in
subparagraph (A), and to any other persons, information
on telemarketing fraud, including--
(i) general information on telemarketing
fraud, including descriptions of the most
common telemarketing fraud schemes;
(ii) information on means of referring
complaints on telemarketing fraud to
appropriate law enforcement agencies, including
the Director of the Federal Bureau of
Investigation and the Attorney General; and
(iii) information, if available, on the
number of complaints of telemarketing fraud
against particular companies and any record of
convictions for telemarketing fraud by
particular companies for which a specific
request has been made; and
(C) refer complaints described in subparagraph (A)
to appropriate entities, including State consumer
protection agencies or entities and appropriate law
enforcement agencies, for potential law enforcement
action.
(2) Central location.--The service under the procedures
under paragraph (1) shall be provided at and through a single
site selected by the Commission for that purpose.
(3) Commencement.--The Commission shall commence carrying
out the service not later than 1 year after the date of
enactment of this Act.
(b) Creation of Fraud Conviction Database.--
(1) Requirement.--The Attorney General shall establish and
maintain a computer database containing information on the
corporations and companies convicted of offenses for
telemarketing fraud under Federal and State law. The database
shall include a description of the type and method of the fraud
scheme for which each corporation or company covered by the
database was convicted.
(2) Use of database.--The Attorney General shall make
information in the database available to the Federal Trade
Commission for purposes of providing information as part of the
service under subsection (a).
(c) Authorization of Appropriations.--There is authorized to be
appropriated such sums as may be necessary to carry out this section.
(d) Expansion of Scope of Telemarketing Fraud Subject to Enhanced
Criminal Penalties.--Section 2325(1) of title 18, United States Code,
is amended by striking ''telephone calls'' and inserting ''wire
communications utilizing a telephone service''.

SEC. 3. ENHANCED CRIMINAL PENALTIES IN CONNECTION WITH MASS MARKETING.

Section 2326 of title 18, United States Code, is amended--
(1) by striking ''A person'' and inserting the following:
''(a) In General.--A person'';
(2) by inserting ''or mass marketing'' after
''telemarketing''; and
(3) by adding at the end the following:
''(b) Mass Marketing Defined.--In this section, the term 'mass
marketing' means a plan, program, promotion, or campaign that is
conducted through solicitation by telephone, mail, the Internet, or
other means to induce a large number of persons to--
''(1) purchase goods or services:
''(2) participate in a contest or sweepstakes; or
''(3) invest for financial profit.''.

SEC. 4. ADDITIONAL FUNDING TO COMBAT FRAUD.

(a) In General.--There is authorized to be appropriated to the
Bureau of Consumer Protection of the Federal Trade Commission
$20,000,000 for each fiscal year to combat telemarketing and mass
marketing fraud, of which not less than $5,000,000 shall be used in
each fiscal year to combat telemarketing and mass marketing fraud
against the elderly.
(b) Definitions.--In this section--
(1) the term ''mass marketing'' has the meaning given the
term in section 2326 of title 18, United States Code, as
amended by this Act; and
(2) the term ''telemarketing'' has the meaning given the
term in section 2325 of title 18, United States Code, as
amended by this Act.

SOLUTION:
Directs the Attorney General to: (1) establish and maintain a computer database of corporations and companies convicted of telemarketing fraud; and (2) make such information available to the FTC.
Amends the Federal criminal code to: (1) include all wire communications utilizing a telephone service (currently, telephone calls) within the scope of telemarketing fraud subject to criminal penalties; and (2) include actions in connection with mass marketing within the scope of such penalties.